Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) Revenue (2020 - 2022)

Historic Revenue for Therapeutics (RAPT) over the last 3 years, with Q2 2022 value amounting to $886000.0.

  • Therapeutics' Revenue rose 195.63% to $886000.0 in Q2 2022 from the same period last year, while for Mar 2023 it was $886000.0, marking a year-over-year decrease of 7258.66%. This contributed to the annual value of $1.5 million for FY2022, which is 5995.28% down from last year.
  • As of Q2 2022, Therapeutics' Revenue stood at $886000.0, which was up 195.63% from $641000.0 recorded in Q1 2022.
  • In the past 5 years, Therapeutics' Revenue registered a high of $1.5 million during Q3 2020, and its lowest value of $641000.0 during Q1 2022.
  • Over the past 3 years, Therapeutics' median Revenue value was $950500.0 (recorded in 2020), while the average stood at $1.0 million.
  • Per our database at Business Quant, Therapeutics' Revenue skyrocketed by 3069.52% in 2021 and then plummeted by 4754.5% in 2022.
  • Over the past 3 years, Therapeutics' Revenue (Quarter) stood at $1.3 million in 2020, then tumbled by 41.94% to $756000.0 in 2021, then rose by 17.2% to $886000.0 in 2022.
  • Its Revenue stands at $886000.0 for Q2 2022, versus $641000.0 for Q1 2022 and $756000.0 for Q4 2021.